Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
10 Août 2018 - 10:56PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number:
001-36086
FOUNDATION MEDICINE, INC.
(Exact name of registrant as specified in its charter)
150 Second
Street
Cambridge, MA 02141
(617)
418-2200
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
N/A
(Titles of all other
classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
Rule 12g-4(a)(2)
|
|
☐
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
Rule
15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date: Two
Pursuant to the requirements of the Securities Exchange Act of 1934, Foundation Medicine, Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: August 10, 2018
|
|
|
|
FOUNDATION MEDICINE, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Troy Cox
|
|
|
|
|
Name:
|
|
Troy Cox
|
|
|
|
|
Title:
|
|
President and Chief Executive Officer
|
Foundation Medicine, Inc. (NASDAQ:FMI)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Foundation Medicine, Inc. (NASDAQ:FMI)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Foundation Medicine, Inc. (delisted) (NASDAQ): 0 recent articles
Plus d'articles sur Foundation Medicine, Inc.